HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma.

AuthorsAlvaro Sanz Rubiales, Virginia de la Cruz, José Ángel Berezo, María Ángeles Torres
JournalJournal of pain and symptom management (J Pain Symptom Manage) Vol. 47 Issue 6 Pg. e7-9 (Jun 2014) ISSN: 1873-6513 [Electronic] United States
PMID24747679 (Publication Type: Case Reports, Letter)
Chemical References
  • Quinazolines
  • Erlotinib Hydrochloride
  • Gefitinib
Topics
  • Adenocarcinoma, Bronchiolo-Alveolar (drug therapy, physiopathology)
  • Aged
  • Bronchi (drug effects, metabolism, pathology)
  • Bronchial Diseases (drug therapy, pathology, physiopathology)
  • Erlotinib Hydrochloride
  • Gefitinib
  • Humans
  • Lung Neoplasms (drug therapy, physiopathology)
  • Male
  • Quinazolines (therapeutic use)
  • Radiography, Thoracic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: